ModernMedicine Resource Center More Topics

Hepatology Resource Center

HCV-related liver disease on the rise in womenThe benefits of HCV treatment will need to extend to all patients in order to stem the rising tide of HCV complications among women and men.
Study: HCV week 4 viral load predicts DAA treatment responseWeek 4 HCV RNA levels have implications for treatment with direct-acting antiviral agents for hepatitis C virus infections.
Researchers: Hepatitis C virus control needs a public health approachA new study suggests a public health approach is necessary to control the spread of hepatitis C virus in urban communities.
DAAs safely treat chronic kidney disease in HCV patientsDirect-acting antiviral therapy with sofosbuvir-based combinations safely and effectively treats HCV infection in patients with early-stage chronic kidney disease.
DAAs improve patient and graft survival after liver transplantLiver transplant outcomes have improved following the introduction of new hepatitis C virus drugs, according to a new study.
Primary care can manage hep C infections with DAAsPrimary care professionals can “substantially expand” HCV treatment in the community, according to new research.
Report highlights critical actions needed to monitor HCV epidemicA new report highlights key missing elements needed to achieve complete elimination of hepatitis C virus.
Direct-acting antivirals reduce liver cancer riskA sustained response to direct-acting antivirals lowers the risk of hepatocellular carcinoma, a new study finds.
Direct-acting antivirals prevent liver cancer recurrenceNew research finds direct-acting antivirals can be given safely to those on liver transplant waitlist.
Sofosbuvir reduces transplant rate in HCV patientsSofosbuvir-based therapy successfully treats HCV patients with decompensated liver disease, according to a new study.